Role of small bioorganic molecules in stem cell differentiation to insulin-producing cells

Bioorg Med Chem. 2006 Oct 1;14(19):6466-74. doi: 10.1016/j.bmc.2006.06.015. Epub 2006 Jun 23.

Abstract

The use of small specific molecules has been instrumental in the modulation of stem cell proliferation and differentiation to obtain insulin-containing cells. Examples include nutrients (glucose, nicotinamide and retinoic acid), acids (butyrate), alkaloids (cyclopamine and conophylline) and pharmacological agents (LY294002 and wortmannin). These molecules, alone or in combination with specific growth factors and hormones, will likely provide key information to design specific culture media in order to obtain customized cells for implantation in diabetes. In addition, the study of such molecules will help to understand the mechanisms involved in stem cell biology as well as contribute to the design of specific drugs for islet repair and regeneration in diabetes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alkaloids / metabolism
  • Androstadienes / pharmacology
  • Animals
  • Butyrates / metabolism
  • Cell Differentiation / physiology*
  • Chromones / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Glucose / metabolism
  • Humans
  • Insulin / biosynthesis*
  • Insulin Antagonists / pharmacology
  • Morpholines / pharmacology
  • Niacinamide / metabolism
  • Stem Cells / metabolism
  • Stem Cells / physiology*
  • Tretinoin / metabolism
  • Wortmannin

Substances

  • Alkaloids
  • Androstadienes
  • Butyrates
  • Chromones
  • Enzyme Inhibitors
  • Insulin
  • Insulin Antagonists
  • Morpholines
  • Niacinamide
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Tretinoin
  • Glucose
  • Wortmannin